{
  "market": "IND",
  "user_profile": {
    "budget": 100000,
    "time_frame": "5 years",
    "risk": "high",
    "goals": "maximum capital appreciation through equities only"
  },
  "allocation": {
    "equity_sleeve": {
      "total_percentage": "100%",
      "total_amount": 100000,
      "stocks": {
        "percentage": "100%",
        "amount": 100000
      },
      "mutual_funds": null
    },
    "diversifiers": {
      "total_percentage": "0%",
      "total_amount": 0,
      "fd": null,
      "gold": null,
      "debt_funds": null,
      "crypto": null
    }
  },
  "stocks_selected": [
    {
      "symbol": "LAURUSLABS.NS",
      "name": "Laurus Labs Limited",
      "sector": "Healthcare",
      "allocated_amount": 8000,
      "current_price": 989.8,
      "pe_ratio": 77.8,
      "price_to_book": 11.12,
      "eps": 12.72,
      "roe": 15,
      "dividend_yield": 0.16,
      "debt_to_equity": 44.83,
      "revenue_growth": 35.1,
      "profit_margins": 10.8,
      "why_selected": "Healthcare sector with strong 1-year momentum (108%), high earnings and revenue growth, favored for aggressive portfolios.",
      "future_outlook": "Expected to continue sector outperformance on pharma innovation; price could see 35-50% upside if trends sustain."
    },
    {
      "symbol": "MCX.NS",
      "name": "Multi Commodity Exchange of India Limited",
      "sector": "Financial Services",
      "allocated_amount": 8000,
      "current_price": 9615,
      "pe_ratio": 70.3,
      "price_to_book": 15.71,
      "eps": 136.73,
      "roe": 25,
      "dividend_yield": 0.32,
      "debt_to_equity": 0.02,
      "revenue_growth": 28.9,
      "profit_margins": 48.4,
      "why_selected": "Market leader in commodity exchange, strong profit margin/ROE, minimal debt, and robust growth. High momentum score.",
      "future_outlook": "Industry tailwinds with growing commodity activity. Upside potential 30-40% if macro trends remain positive."
    },
    {
      "symbol": "NAVINFLUOR.NS",
      "name": "Navin Fluorine International Limited",
      "sector": "Basic Materials",
      "allocated_amount": 7000,
      "current_price": 6041,
      "pe_ratio": 68.2,
      "price_to_book": 8.57,
      "eps": 88.55,
      "roe": 14.6,
      "dividend_yield": 0.22,
      "debt_to_equity": 32.68,
      "revenue_growth": 46.3,
      "profit_margins": 15.9,
      "why_selected": "Specialty chemicals play with top revenue growth and high sector momentum—great for aggressive bets on export growth.",
      "future_outlook": "May see 25-35% returns as global specialty chemical demand rises and domestic capex drives profitability."
    },
    {
      "symbol": "BEL.NS",
      "name": "Bharat Electronics Limited",
      "sector": "Industrials",
      "allocated_amount": 7000,
      "current_price": 422.35,
      "pe_ratio": 54.29,
      "price_to_book": 14.33,
      "eps": 7.78,
      "roe": 29,
      "dividend_yield": 0.56,
      "debt_to_equity": 0.27,
      "revenue_growth": 25.8,
      "profit_margins": 22.6,
      "why_selected": "Defence/industrial innovator; positive long-term momentum, strong profit margins and ROE, almost debt-free, substantial recent price appreciation.",
      "future_outlook": "India’s defence push should allow BEL to see further upside, possibly 20-30% appreciation given strong fundamentals."
    },
    {
      "symbol": "HINDALCO.NS",
      "name": "Hindalco Industries Limited",
      "sector": "Basic Materials",
      "allocated_amount": 7300,
      "current_price": 804.65,
      "pe_ratio": 10.08,
      "price_to_book": 1.32,
      "eps": 79.85,
      "roe": 14.2,
      "dividend_yield": 0.63,
      "debt_to_equity": 57.57,
      "revenue_growth": 13.5,
      "profit_margins": 7,
      "why_selected": "Strong value metrics (low PE/PB), sector momentum, large cap with significant international business roots; fits high-risk equity sleeve.",
      "future_outlook": "Expected to benefit from metal and commodity demand; high potential for 25%+ growth if export cycle resumes."
    },
    {
      "symbol": "CEATLTD.NS",
      "name": "CEAT Limited",
      "sector": "Consumer Cyclical",
      "allocated_amount": 6700,
      "current_price": 4110.1,
      "pe_ratio": 33.54,
      "price_to_book": 3.63,
      "eps": 122.54,
      "roe": 11.2,
      "dividend_yield": 0.73,
      "debt_to_equity": 67.99,
      "revenue_growth": 14.2,
      "profit_margins": 3.5,
      "why_selected": "Auto component play riding recent recovery, strong year-on-year momentum and sector cyclicality; risk-balanced for high growth.",
      "future_outlook": "EV shift and auto demand could add 20-25% returns over next 1-2 years if sector momentum continues."
    },
    {
      "symbol": "POWERINDIA.NS",
      "name": "Hitachi Energy India Limited",
      "sector": "Industrials",
      "allocated_amount": 6500,
      "current_price": 21491,
      "pe_ratio": 131.11,
      "price_to_book": 20.9,
      "eps": 163.91,
      "roe": 23.9,
      "dividend_yield": 0.03,
      "debt_to_equity": 1.84,
      "revenue_growth": 18.8,
      "profit_margins": 10.5,
      "why_selected": "Growth leader in clean energy and grid tech, huge one-year price surge (77%). Consistent earnings and sector tailwinds.",
      "future_outlook": "Renewables focus should drive 25-30%+ growth if orders strengthen; momentum strong."
    },
    {
      "symbol": "MANAPPURAM.NS",
      "name": "Manappuram Finance Limited",
      "sector": "Financial Services",
      "allocated_amount": 6500,
      "current_price": 274.75,
      "pe_ratio": 53.14,
      "price_to_book": 1.85,
      "eps": 5.17,
      "roe": 3.36,
      "dividend_yield": 0.73,
      "debt_to_equity": 301.61,
      "revenue_growth": -30.9,
      "profit_margins": 12.8,
      "why_selected": "High momentum and recent price performance. Strong position in affordable finance with scope for deep penetration in semi-urban India.",
      "future_outlook": "If NPA risks are managed, could see 20-25% CAGR, especially if gold loan and micro-lending segments continue booming."
    },
    {
      "symbol": "DRREDDY.NS",
      "name": "Dr. Reddy's Laboratories Limited",
      "sector": "Healthcare",
      "allocated_amount": 6500,
      "current_price": 1235.8,
      "pe_ratio": 17.57,
      "price_to_book": 2.87,
      "eps": 70.33,
      "roe": 17.4,
      "dividend_yield": 0.65,
      "debt_to_equity": 16.17,
      "revenue_growth": 9.8,
      "profit_margins": 17.1,
      "why_selected": "India’s pharma export leader, resilient and innovative, with international upside and medium risk.",
      "future_outlook": "Steady capital gains, 15-18% returns, especially if branded generics and API exports accelerate."
    },
    {
      "symbol": "THYROCARE.NS",
      "name": "Thyrocare Technologies Limited",
      "sector": "Healthcare",
      "allocated_amount": 6500,
      "current_price": 1456.4,
      "pe_ratio": 60.41,
      "price_to_book": 14.44,
      "eps": 24.11,
      "roe": 24.7,
      "dividend_yield": 2.02,
      "debt_to_equity": 4.62,
      "revenue_growth": 22.1,
      "profit_margins": 16.7,
      "why_selected": "Diagnostics leader, high growth and momentum, defensive stock with upside as preventive care demand expands.",
      "future_outlook": "Might outperform if health awareness trends grow; possible 20%+ upside on strong rural penetration."
    }
  ],
  "mutual_funds_selected": null,
  "what_if_analysis": {
    "conservative_return": "Assume 10% CAGR: ₹100,000 grows to around ₹161,000 after 5 years.",
    "moderate_return": "Assume 14% CAGR (reasonable for aggressive stocks): ₹100,000 grows to around ₹191,000 after 5 years.",
    "optimistic_return": "Assume 18% CAGR (if bull market persists): ₹100,000 grows to approx ₹227,000 in 5 years."
  },
  "summary": "This portfolio is fully allocated to high-momentum, high-growth stocks spanning healthcare, financials, basic materials, industries, and consumer cyclicals. Sector spread mitigates specific risks, and aggressive picks are oriented towards strong historical returns. The objective is maximum capital appreciation, accepting volatility and sharp corrections for long-term higher returns.",
  "risk_analysis": {
    "mild_crash": "A 10% market dip would reduce portfolio to ₹90,000; recovery could be faster due to high-beta picks.",
    "moderate_crash": "A 20% correction means ₹80,000 value; some sectors may lag in recovery, but pharma and consumer may buffer volatility.",
    "severe_crash": "A 30% drawdown means ₹70,000; expect some stocks to suffer deeper individual falls.",
    "summary": "This strategy accepts volatility in exchange for growth. Risk is higher than average, so periodic review and rebalancing are advised if fundamentals change."
  },
  "education_tips": {
    "diversification_importance": "Spreading investments across sectors (healthcare, finance, industry) limits portfolio damage from sector-specific shocks.",
    "long_term_perspective": "Over 5 years, compounding works best. Ignore short-term dips; focus on company growth fundamentals.",
    "rebalancing_strategy": "Review annually. If a stock underperforms or fundamentals worsen, rotate to stronger charts or emerging leaders.",
    "understanding_risk": "High risk profiles may see larger swings. Do not panic on corrections; volatility is a feature, not a bug, in aggressive portfolios."
  }
}